AbCellera Biologics (ABCL) Earnings Date & Reports

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABCL is expected to report earnings to rise 13.33% to -17 cents per share on August 06

AbCellera Biologics ABCL Stock Earnings Reports

Q2'26

Est.

$-0.17

Q1'26

Beat

by $0.01

Q4'25

Missed

by $0.35

Q3'25

Missed

by $0.05

Q2'25

Beat

by $0.02

The last earnings report on May 11 showed earnings per share of -15 cents, beating the estimate of -15 cents. With 2.96M shares outstanding, the current market capitalization sits at 1.60B.

View a ticker or compare two or three

Compare

ABCL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ABCL